Cargando…
MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression
Multiple sclerosis is a chronic autoimmune disease of the central nervous system. It is the main cause of non-traumatic neurological disability in young adults. Multiple sclerosis mostly affects people aged 20–50 years; however, it can occur in young children and much older adults. Factors identifie...
Autores principales: | Martinez, Bridget, Peplow, Philip V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975152/ https://www.ncbi.nlm.nih.gov/pubmed/31638082 http://dx.doi.org/10.4103/1673-5374.266905 |
Ejemplares similares
-
MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis
por: Martinez, Bridget, et al.
Publicado: (2020) -
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
por: Martinez, Bridget, et al.
Publicado: (2019) -
MicroRNAs as diagnostic and prognostic biomarkers of age-related macular degeneration: advances and limitations
por: Martinez, Bridget, et al.
Publicado: (2020) -
MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022) -
Blood microRNAs as potential diagnostic markers for hemorrhagic stroke
por: Martinez, Bridget, et al.
Publicado: (2017)